These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 23303263

  • 1. [Urinary tract infection by multiresistant Escherichia coli and Klebsiella pneumoniae: case report].
    Martín-Pozo Á, Oteo J, Sáez D, Alós JI.
    Rev Esp Quimioter; 2012 Dec; 25(4):295-6. PubMed ID: 23303263
    [No Abstract] [Full Text] [Related]

  • 2. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.
    Yang YS, Ku CH, Lin JC, Shang ST, Chiu CH, Yeh KM, Lin CC, Chang FY.
    J Microbiol Immunol Infect; 2010 Jun; 43(3):194-9. PubMed ID: 21291846
    [Abstract] [Full Text] [Related]

  • 3. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR, Nichol KA, Nicolle LE, DeCorby M, McCracken M, Mulvey MR, Zhanel GG.
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract] [Full Text] [Related]

  • 4. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P, Trakulsomboon S, Dejsirilert S, Thongmali O, Sawanpanyalert P, Aswapokee N, Buppanharun W.
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [Abstract] [Full Text] [Related]

  • 5. [Strain of Escherichia coli resistant to broad-spectrum cephalosporin and amoxicillin/clavulanic acid].
    Martín-Pozo A, Alós JI.
    Rev Esp Quimioter; 2012 Sep; 25(3):222-3. PubMed ID: 22987271
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P, Garzón D, Mattar S.
    Braz J Infect Dis; 2012 Sep; 16(5):420-5. PubMed ID: 22964287
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
    Yu YS.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 17; 84(22):1918-20. PubMed ID: 15631810
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
    Marquet A, Vibet MA, Caillon J, Javaudin F, Chapelet G, Montassier E, Batard E.
    Microb Drug Resist; 2018 Sep 17; 24(7):987-994. PubMed ID: 29489447
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F, Kavanagh S, Manecksha R, Thornhill J, Fennell JP.
    BMC Infect Dis; 2016 Nov 03; 16(1):620. PubMed ID: 27806687
    [Abstract] [Full Text] [Related]

  • 14. [Nosocomial infection due to ESBL-producing bacteria].
    Yagi T.
    Nihon Rinsho; 2003 Mar 03; 61 Suppl 3():90-4. PubMed ID: 12717952
    [No Abstract] [Full Text] [Related]

  • 15. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Apisarnthanarak A, Bailey TC, Fraser VJ.
    Clin Infect Dis; 2008 Apr 15; 46(8):1322-3. PubMed ID: 18444877
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M, Sekar U.
    J Assoc Physicians India; 2010 Dec 15; 58 Suppl():41-4. PubMed ID: 21568008
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
    Noguera O, López-Riquelme N, Rodríguez JC, Santibañez M, Alvarez L, Galiana A, Ruiz-García M, López-García P, Royo G.
    Int J Antimicrob Agents; 2012 Aug 15; 40(2):189-90. PubMed ID: 22727771
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.